Status and phase
Conditions
Treatments
About
The primary objective of this study is to assess the safety and tolerability of SHR-1918 injection in healthy subjects. In addition, this study will provide information on pharmacokinetics and pharmacodynamics of SHR-1918 injection in healthy subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1.History of disease or treatment for:
2.Any one of the following tests at screening :
3.General:
4.The Investigator determines that the subjects have poor compliance or have any factors that may prevent them from participating in the study, including, but not limited to, the study placing the subjects at unacceptable risk or possibly interfering with the study results.
Primary purpose
Allocation
Interventional model
Masking
72 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Chao Lv; Miaomiao Shi
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal